Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Keisuke Yamagishi"'
Publikováno v:
Journal of Materials Research and Technology, Vol 32, Iss , Pp 2578-2583 (2024)
This study addresses the transformation-induced plasticity (TRIP) effect observed in bcc single-phase Mg–Sc alloys, aiming to circumvent the strength-ductility tradeoff inherent in traditional Mg-based alloys. Introducing a third element (X = Zn, Y
Externí odkaz:
https://doaj.org/article/e4887c252e0e464bbd0ac0941c742b16
Autor:
Fumine Tsukamoto, Koji Arihiro, Mina Takahashi, Ken-ichi Ito, Shozo Ohsumi, Seiki Takashima, Takaaki Oba, Masayuki Yoshida, Kazuki Kishi, Keisuke Yamagishi, Takayuki Kinoshita
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background The benefits of postoperative chemotherapy in patients with estrogen receptor (ER)-positive breast cancer remain unclear. The use of tumor grade, Ki-67, or ER expression failed to provide an accurate prognosis of the risk of relap
Externí odkaz:
https://doaj.org/article/3f42261e6f1d42f2bb5fcc6fdaaa5ceb
Autor:
Yohei Nishikawa, Masahito Hosokawa, Toru Maruyama, Keisuke Yamagishi, Tetsushi Mori, Haruko Takeyama
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0138733 (2015)
Whole genome amplification (WGA) is essential for obtaining genome sequences from single bacterial cells because the quantity of template DNA contained in a single cell is very low. Multiple displacement amplification (MDA), using Phi29 DNA polymeras
Externí odkaz:
https://doaj.org/article/0e6fd38bbb5c43cfb5391c211b6dc2d9
Autor:
Yuria Saito, Kanako C. Hatanaka, Ayae Nange, Mitsuru Taniguchi, Keisuke Yamagishi, Yoshihiro Matsuno, Asami Okumura, Kengo Hamasaki, Yutaka Hatanaka, Hiroko Yamashita
Publikováno v:
Anticancer Research. 43:707-711
Background A subset of patients with estrogen receptor (ER)-positive, HER2-negative, and node-negative breast cancer experience recurrences. Predicting patients who will have recurrences within 5 years of surgery is essential so that patients can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a062c5e443198214cd30520becc60bec
https://doi.org/10.21873/anticanres.16209
https://doi.org/10.21873/anticanres.16209
Autor:
Eiji Shinto, Eiji Oki, Mototsugu Shimokawa, Shigeki Yamaguchi, Megumi Ishiguro, Seiji Hasegawa, Yasumasa Takii, Hideyuki Ishida, Tetsuya Kusumoto, Masaru Morita, Naohiro Tomita, Manabu Shiozawa, Masafumi Tanaka, Heita Ozawa, Yojiro Hashiguchi, Shinobu Ohnuma, Sachiyo Tada, Tomoko Matsushima, Keisuke Yamagishi, Kazuo Hase
Publikováno v:
Annals of Surgical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0ebf626ca6a824dfe8d87575ae78239
https://doi.org/10.1245/s10434-023-13594-1
https://doi.org/10.1245/s10434-023-13594-1
Publikováno v:
Metallurgical and Materials Transactions A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::716a6f4d5f97ca809c79f9c628202b8f
https://doi.org/10.1007/s11661-023-07062-4
https://doi.org/10.1007/s11661-023-07062-4
Publikováno v:
The Minerals, Metals & Materials Series ISBN: 9783031226441
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98b8f9fdf331b74477003ff9db72b7bd
https://doi.org/10.1007/978-3-031-22645-8_34
https://doi.org/10.1007/978-3-031-22645-8_34
Publikováno v:
MATERIALS TRANSACTIONS. 61:2270-2275
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7960128b7e0fab9838781dd1a8c5845
https://doi.org/10.2320/matertrans.mt-m2020244
https://doi.org/10.2320/matertrans.mt-m2020244
Publikováno v:
Journal of Alloys and Compounds. 931:167507
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6cf4d2198cae1f868be298ad3cae5ec
https://doi.org/10.1016/j.jallcom.2022.167507
https://doi.org/10.1016/j.jallcom.2022.167507
Autor:
Sachiyo Tada, Tomoko Matsushima, Robert Schuetz, Seigo Nakamura, Yasuto Naoi, Debu Tripathy, Yuki Matsunaga, Jose Rodrigo Espinosa Fernandez, Jared David Acoba, Yee Chung Cheng, Aysegul A. Sahin, Keisuke Yamagishi, Fei Yang, Rubie Sue Jackson, Takeo Fujii, Hiroko Masuda, Naoto T. Ueno, Arup Kumar Sinha, Shinzaburo Noguchi, Akshara Singareeka Raghavendra, Anjali James
Purpose A subset of patients with intermediate 21-gene signature assay recurrence score may benefit from adjuvant chemoendocrine therapy, but a predictive strategy is needed to identify such patients. The 95-gene signature assay was tested to stratif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1005a191ee9e036668737ba00ca52c4
https://doi.org/10.21203/rs.3.rs-496843/v1
https://doi.org/10.21203/rs.3.rs-496843/v1